Characterizing expanded access and compassionate use programs for experimental drugs by Jennifer E. Miller, Joseph S. Ross, Kenneth I. Moch, Arthur L. Caplan

Get full text

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis by Joshua D. Wallach, Anita T. Luxkaranayagam, Sanket S. Dhruva, Jennifer E. Miller, Joseph S. Ross

Get full text

Drug repurposing: a systematic review on root causes, barriers and facilitators by Nithya Krishnamurthy, Alyssa A. Grimshaw, Sydney A. Axson, Sung Hee Choe, Jennifer E. Miller

Get full text

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting by Adam T. Phillips, Nihar R. Desai, Harlan M. Krumholz, Constance X. Zou, Jennifer E. Miller, Joseph S. Ross

Get full text

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study by Constance X. Zou, Jessica E. Becker, Adam T. Phillips, James M. Garritano, Harlan M. Krumholz, Jennifer E. Miller, Joseph S. Ross

Get full text

Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of t... by Anand D. Gopal, Joshua D. Wallach, Jenerius A. Aminawung, Gregg Gonsalves, Rafael Dal-Ré, Jennifer E. Miller, Joseph S. Ross

Get full text